The Frequency and Type of K-RAS Mutations in Mexican Patients With Colorectal Cancer-Reference-Cited by-同舟云学术

The Frequency and Type of K-RAS Mutations in Mexican Patients With Colorectal Cancer

Published:2017-06 Issue:3 Volume:40 Page:274-276
ISSN:0277-3732
Container-title:American Journal of Clinical Oncology
language:en
Short-container-title:

Author:

Cárdenas-Ramos Susana G.,Alcázar-González Gregorio,Reyes-Cortés Luisa M.,Torres-Grimaldo Abdiel A.,Calderón-Garcidueñas Ana L.,Morales-Casas José,Flores-Sánchez Patricia,De León-Escobedo Raúl,Gómez-Díaz Antonio,Moreno-Bringas Carmen,Sánchez-Guillén Jorge,Ramos-Salazar Pedro,González-de León César,Barrera-Saldaña Hugo A.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Oncology

Reference20 articles.

1. Worldwide variations in colorectal cancer;Center;Cancer J Clin,2009

2. Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging;O’Connell;J Natl Cancer Inst,2004

3. A 35-year report of the study of group on gastrointestinal cancer in Mexico City: variations in frequency of different digestive tract neoplasms among different socioeconomic statuses;Villalobos Pérez;Gac Med Mex,2014

4. Genetic ancestry is associated with colorectal adenomas and adenocarcinomas in Latino populations;Hernandez-Suarez;Eur J Hum Genet,2014

5. Management of a patient with metastatic colorectal cancer and liver metastases;Saif;Case Rep Oncol Med,2014

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. KRAS Exon 2 Mutations in Patients with Sporadic Colorectal Cancer: Prevalence Variations in Mexican and Latin American Populations;Cancers;2024-06-25

2. 9-ING-41, a Small Molecule Inhibitor of GSK-3β, Potentiates the Effects of Chemotherapy on Colorectal Cancer Cells;Frontiers in Pharmacology;2021-12-09

3. Molecular Heterogeneity of Cervical Cancer Among Different Ethnic/Racial Populations;Journal of Racial and Ethnic Health Disparities;2021-11-05

4. Complete Screening of Exons 2, 3, and 4 of KRAS and NRAS Genes Reveals a Higher Number of Clinically Relevant Mutations than Food and Drug Administration Quantitative Polymerase Chain Reaction-Based Commercial Kits;Revista de investigaci�n Cl�nica;2020-12-22

5. KRAS, NRAS, and BRAF mutation prevalence, clinicopathological association, and their application in a predictive model in Mexican patients with metastatic colorectal cancer: A retrospective cohort study;PLOS ONE;2020-07-06